Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Palbociclib (100mg) Capsule
Therapeutic Category
Dosage Form
Packaging Type
Packaging
Price
₹/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Palbocare 100 Capsule containing Palbociclib is used in oncology care for the treatment of certain hormone receptor-positive and HER2-negative breast cancer cases. It helps regulate cancer cell growth and supports comprehensive cancer management.
Palbociclib works as a cyclin-dependent kinase (CDK) 4/6 inhibitor that helps slow the progression of cancer cells by interfering with cellular division and proliferation processes.
The capsule is widely utilized in oncology practice as part of targeted cancer treatment protocols, leading to consistent demand in specialized cancer care settings.
With increasing adoption of targeted oncology therapies and growing demand for advanced cancer care solutions, this product offers strong business potential for retailers and distributors. Its targeted mechanism of action, high therapeutic relevance, and steady market demand make it a reliable product for growth in the oncology segment.
Some patients may experience fatigue, nausea, diarrhea, mouth sores, hair thinning, decreased appetite, or infections. Common laboratory findings include reduced white blood cell counts, anemia, and thrombocytopenia. Rarely, severe infections or lung-related complications may occur and require immediate medical attention.
Palbocare 100 Capsule is indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, usually in combination with appropriate endocrine therapy as prescribed by an oncologist. It helps slow cancer progression and improve treatment outcomes.
This medicine should be used strictly under the supervision of a qualified oncologist. Regular monitoring of blood counts is essential during treatment. Patients should promptly report signs of infection, fever, unusual bleeding, or breathing difficulties. Avoid self-medication and follow the prescribed treatment schedule carefully.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the capsules in their original packaging and out of reach of children. Important Regulatory Note: Palbociclib is a prescription-only anticancer medicine that should be dispensed and used only under specialist medical supervision.
Composition : Abiraterone 250 Mg Tablet
Composition : Acebrophylline (100mg) + Acetylcysteine (600mg)
Composition : Acetylcysteine (600mg) effervescent
Composition : Paclitaxel (100mg) Injection
Composition : Aceclofenac (200mg) + Rabeprazole (20mg) Capsule
Composition : Lactic acid bacillus (100Million spores) + Saccharomyces boulardii (250mg) + Zinc (10mg)
Composition : Glimepiride (1mg) + Metformin (500mg) SR Bilayered Smart Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Palbociclib 100mg Capsule has specialized, high-value demand in the oncology and hospital oncology segment, making it a niche but premium product for medical distributors, wholesalers, and pharma franchise partners dealing in cancer care portfolios.
Medical distributors and agencies can benefit from hospital-based oncology prescriptions under strict specialist supervision. Palbociclib 100mg is a CDK4/6 inhibitor used in targeted cancer therapy Commonly prescribed for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (as per oncologist guidance) Used in combination therapy protocols in oncology treatment plans Requires strict medical supervision due to its targeted anticancer action and safety monitoring Mainly supplied in hospital oncology departments and cancer specialty centers This strengthens a specialized oncology and hospital critical-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Palbociclib 100mg Capsule with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from high-value institutional demand, oncology specialist prescriptions, limited competition, and hospital procurement opportunities, along with reliable supply chain support and premium margin potential in the oncology segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional pharmaceutical support and a dependable supply chain for oncology-focused business growth.